Fn. Hussain et al., MESALAZINE RELEASE FROM A PH DEPENDENT FORMULATION - EFFECTS OF OMEPRAZOLE AND LACTULOSE COADMINISTRATION, British journal of clinical pharmacology, 46(2), 1998, pp. 173-175
Aims Delayed-release formulations of mesalazine often rely on the gast
rointestinal luminal pH profile to deliver 5-aminosalicylic acid (5ASA
) to the colon. The aim of this study was to examine the influence of
luminal pH on mesalazine release. Methods We studied, the effect of co
-administration of omeprazole and lactulose on the steady-state pharma
cokinetics of Eudragit S-coated mesalazine in healthy volunteers. Resu
lts No significant changes in urinary or faecal levels of 5ASA or its
main metabolite, N-acetyl 5ASA, were apparent. Conclusions This study
suggests that co-administration of omeprazole and lactulose does not i
mpair the release of delayed-release mesalazine.